Additional file 1 of Injectable hydrogel nanoarchitectonics with near-infrared controlled drug delivery for in situ photothermal/endocrine synergistic endometriosis therapy

article OA: green CC0
View on OpenAlex View at publisher
AI-generated summary by claude@2026-06, 2026-06-12

This paper presents injectable hydrogels with near-infrared controlled drug delivery for photothermal/endocrine synergistic endometriosis therapy, detailing SEM images, extinction coefficients, temperature records, standard curves, UV-vis spectra, rheological properties, degradation curves, and cell biocompatibility.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Additional file 1: Figure S1. SEM images of PDA. Figure S2. The extinction coefficient of PDA at 808 nm. Figure S3. The temperature record of a single photoperiod of PDA solution. Figure S4. The standard curve of LTZ. Figure S5. UV-vis spectra of LTZ under different temperature or pH condition. Figure S6. The ratio of G'' to G' was expressed by tan δ.Figure S7. The degradation curve of LTZ. Figure S8.The biocompatibility of 3T3 and HUVEC cells.

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (51)

Source provenance

openalex
last seen: 2026-05-13T20:12:55.465734+00:00
License: CC0 · commercial use OK